A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis

Benzer Materyaller

• Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis
  Yazar:: Pariser, David M., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials
  Yazar:: Pariser, David M., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study
  Yazar:: Hebert, Adelaide A., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials
  Yazar:: Hebert, Adelaide A., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
  Yazar:: Lamb, Yvette N.
  Baskı/Yayın Bilgisi: (2019)